| 영문 | heparin | 한글 | 헤파린 |
|---|---|---|---|
| 설명 | 혈액 응고를 막는 작용을 하는 다당류의 황산에스테르. 고등동물의 각종 조직에 널리 분포되어 있으며, 수술 후의 혈전증을 막는 데 쓴다. 혈액응고란 지혈의 한 과정으로 섬유소란 물질을 만들어 내는 과정이다. 이 섬유소는 손상된 혈관의 부위에 작용하여 여러 가지 세포들을 얽어 묶는 역할을 하여 결국 손상된 혈관에서 혈액의 소실을 막는다. 이 섬유소는 트롬빈에 의해 섬유소원에서 전환된다. 헤파린이라는 물질은 이 트롬빈을 억제하는 항트롬빈을 활성화하는 물질이다. |
||
| hepar | 1. <chemistry> Liver of sulphur; a substance of a liver-brown colour, sometimes used in medicine. It is formed by fusing sulphur with carbonates of the alkalies (especially. Potassium), and consists essentially of alkaline sulphides. Synonym: hepar sulphuris . 2. Any substance resembling hepar proper, in appearance; specifically, in homeopathy, calcium sulphide, called also hepar sulphuris calcareum . <chemistry> Hepar antimonii, a substance, of a liver-brown colour, obtained by fusing together antimony sulphide with alkaline sulphides, and consisting of sulphantimonites of the alkalies. Synonym: liver of antimony. Origin: L. Hepar, hepatis, the liver, Gr. Source: Websters Dictionary (01 Mar 1998) |
|---|---|
| heparan N-sulfatase | <enzyme> An enzyme that participates in the stepwise degradation of heparan sulfate; heparan N-sulfatase hydrolyzes the sulfate moiety attached to the amino group of the glucosamine residue of heparan sulfate; a deficiency of this enzyme is associated with mucopolysaccharidose IIIA (Sanfilippo's syndrome A). (05 Mar 2000) |
| heparan sulfate | <chemical> Heparitin, sulfate. A glycosaminoglycan occurring in the liver, aorta, and lung. It has a structure similar to heparin, but there are more n-acetyl groups and fewer o- and n-sulfate groups. It is an accumulation product in several mucopolysaccharidoses. Chemical name: Heparitin, sulfate (12 Dec 1998) |
| heparan sulfate D-glucosaminyl 3-O-sulfotransferase | <enzyme> Involved in biosynthesis of heparan sulfate proteoglycans Registry number: EC 2.8.2.- Synonym: hsg 3-o-sulfotransferase (26 Jun 1999) |
| heparan sulfate proteoglycan | Ubiquitous macromolecules associated with the cell surface and extracellular matrix of a wide range of cells of vertebrate and invertebrate tissues. They are essential cofactors in cell-matrix adhesion processes, in cell-cell recognition systems, and in receptor-growth factor interactions. (12 Dec 1998) |
| heparan sulfate sulfatase | <enzyme> Probable defect in sanfilippo a syndrome Registry number: EC 3.1.6.- Synonym: heparan sulphatase (26 Jun 1999) |
| heparan sulfate-N-deacetylase-N-sulfotransferase | <enzyme> Catalyses both the n-deacetylation and the n-sulfation reactions that begin modification of heparan sulfate's oligosaccharide backbone Registry number: EC 2.8.2.- Synonym: hs-ndac-nst (26 Jun 1999) |
| heparan sulphate | Constituent of membrane associated proteoglycans. The heparan sulphate binding domain of NCAM is proposed to augment NCAM NCAM interactions, suggesting that cell cell bonds mediated by NCAM may involve interactions between multiple ligands. The putative heparin binding site on NCAM is a 28 aa peptide shown to bind both heparin and retinal cells, as well as to inhibit retinal cell adhesion to NCAM. This strengthens the argument that that this site contributes directly to NCAM mediated cell cell adhesion. (18 Nov 1997) |
| heparan-sulfate 2-sulfotransferase | <enzyme> An o-sulfotransferase that catalyses transfer of sulfate from 3'-phosphoadenosine 5'-phosphosulfate to l-iduronic acid at position 2 of heparan sulfate; genbank d88811 Registry number: EC 2.8.2.- Synonym: hs2st enzyme (26 Jun 1999) |
| heparanase | <enzyme> Tumour cell enzyme has endoglycosidase activity which degrades glycosaminoglycans into fragments of intermediate size Registry number: EC 3.2.1.- (26 Jun 1999) |
| heparin | <drug> Sulphated mucopolysaccharide, found in granules of mast cells, that inhibits the action of thrombin on fibrinogen by potentiating antithrombins, thereby interfering with the blood clotting cascade. Platelet factor IV will neutralise heparin. (18 Nov 1997) |
| heparin antagonists | Coagulant substances inhibiting the anticoagulant action of heparin. (12 Dec 1998) |
| heparin binding growth factor | <growth factor> Acidic fibroblast growth factor (alpha FGF, HBGF 1) and basic FGF (beta FGF, HBGF 2) are the two founder members of a family of structurally related growth factors for mesodermal or neuroectodermal cells. Synonym: heparin binding growth factor. Acronym: FGF (18 Nov 1997) |
| heparin cofactor II | <chemical> A sulfated plasma protein with the mw of approximately 66kda. The protein is an inhibitor of thrombin in plasma that is activated by dermatan sulfate or heparin. It is a member of the serpin superfamily. Pharmacological action: serine proteinase inhibitors. Chemical name: Heparin cofactor II (12 Dec 1998) |
| heparin complement | The protein component of heparin in blood. (05 Mar 2000) |
Synonyms : Proteoheparan Sulfate, Proteoglycan, Heparan Sulfate, Proteoglycans, Heparan Sulfate, Sulfate Proteoglycans, Heparan
Synonyms : Liquaemin, Sodium Heparin, Heparin, Sodium, alpha Heparin
Synonyms : Antagonists, Heparin
Synonyms : Heparin Co-Factor II, Co-Factor II, Heparin, Cofactor II, Heparin, Heparin Co Factor II
Synonyms : Neutralase, Eliminase, Heparin, I, Heparinase, Lyase, Heparin
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|---|---|---|---|
|
중외헤파린나트륨주사액1,000단위 - 새창
|
중외 |
A02104111 | Heparin sodium | 전문의약품 | 급여 | 분업예외의약품 |
|
메디텍헤파린나트륨주사액25,000단위 - 새창
|
한국메디텍 |
A20500531 | Heparin sodium | 전문의약품 | 삭제 | 분업예외의약품 |
|
한림헤파린나트륨주25,000단위 - 새창
|
한림제약 |
A37800521 | Heparin sodium | 전문의약품 | 급여 |
|
중외헤파린주사액 - 새창
|
중외 |
A02101541 | Heparin sodium | 전문의약품 | 급여 | 분업예외의약품 |
|
신풍헤파린나트륨주25,000단위 - 새창
|
신풍제약 |
A00302871 | Heparin sodium | 전문의약품 | 급여 | 분업예외의약품 |
|
헤파리겐정100mg - 새창
|
보령제약 |
A09300411 | Timonacic | 일반의약품 | 급여 |
|
헤파리겐정200mg - 새창
|
보령제약 |
A09301371 | Timonacic | 일반의약품 | 삭제 |
|
메디텍헤파린나트륨주사액1,000단위 - 새창
|
한국메디텍 |
A20500541 | Heparin sodium | 전문의약품 | 삭제 | 분업예외의약품 |
|
유영헤파린칼슘주 - 새창
|
유영제약 |
A34002541 | Heparin calcium | 전문의약품 | 삭제 | 분업예외의약품 |
|
애보트헤파린나트륨주10000단위 - 새창
|
Abbott |
W01860131 | Heparin sodium | 전문의약품 | 삭제 |
| heparin |
a polysaccharide produced in basophils (especially in the lung and liver) and that inhibits the activity of thrombin in coagulation of the blood; it (trade names Lipo-Hepin and Liquaemin) is used as an anticoagulant in the treatment of thrombosis and in heart surgery
출처: wordnet.princeton.edu/perl/webwn
|
|---|---|
| heparin cofactor II |
a serine proteinase inhibitor of the serpin family; it is a single-chain glycoprotein, M r 65,000, that inhibits thrombin. It resembles antithrombin III in being markedly stimulated by heparin; it differs in that it binds and is activated by dermatan sulfate and in that it does not inhibit any other activated coagulation factors.
출처: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
|
| heparin |
A naturally occurring mucopolysaccharide that acts in the body as an antithrombin factor to prevent intravascular clotting. Heparin is used therapeutically as an anticoagulant.
출처: virtualtrials.com/dictionary.cfm
|
| heparin |
A drug that helps prevent blood clots from forming.
출처: nydailynews.healthology.com/nydailynews/15836.htm
|
| heparin |
A drug that decreases the blood's ability to clot.
출처: www.thebody.com/hivnews/aidscare/dec97/pullout.htm...
|
| hepar | a polysaccharide produced in basophils (especially in the lung and liver) and that inhibit the activity of thrombin in coagulation of the blood |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
